Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
53.00    3.00 (6.00%)
Bid:
52.00
Ask:
54.00
Spread: 2.00 (3.846%)
Market Cap: £101.68m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Atlantis Water Project Update

29 Apr 2013 07:00

RNS Number : 4262D
Iofina PLC
29 April 2013
 



 

 

29 April 2013

 

 

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Atlantis Water Project Update

 

Iofina, a specialist in the exploration and production of iodine and specialty chemical iodine derivatives,

is pleased to provide the following update in respect of its Atlantis Water Project.

Based on initial responses from and discussions with the Montana Department of Natural Resource Conservation ("DNRC") Water Resources Office following their receipt of the Company's water right permit application, the Company has elected to amend its water permit application in an effort to expedite its plan to market 10,000 acre-feet per year (c.200,000 barrels per day) of freshwater in eastern Montana.

The possibility of needing to amend the original application was anticipated and envisioned as part of this process and the Company has decided to amend its application to expedite the application process. The Company's revised application is to develop a water depot for 3,800 acre-feet per year based on customers' needs at the current planned location. The Company has secured strategic locations for the first water pumping station and place of sale for its initial terminal and recently submitted an amended application to reflect this. The Company is actively acquiring additional strategically placed sites, based on demand and ease of transportation, for two additional depots that, together with the initial depot, will total over 10,000 acre-feet per year as planned.

After discussing the status of the application with the central Water Resources Office, the Company was informed that the department removed the original application from its website, but has not terminated the original application. The original application remains valid pending receipt of the amended application.

 

About Iofina

Iofina specialises in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, California, Montana, Oklahoma and Wyoming. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilises its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.  

 

For further information, please contact:

 

Stuart Eaton, Executive Operations Officer

Iofina plc

Tel: +44(0)7500 042 516

www.iofina.com

 

Dr Chris Fay, Executive Chairman

Iofina plc

Tel: +44(0)7747 693 486

Ben Colegrave/Chris Sim/Neil Elliot

Investec

Tel: +44(0)20 7597 5970

 

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEANLPASNDEFF
Date   Source Headline
23rd Sep 20214:35 pmRNSPrice Monitoring Extension
22nd Sep 20219:58 amRNSHolding(s) in Company
10th Sep 20214:15 pmRNSHolding(s) in Company
10th Sep 20213:25 pmRNSHolding(s) in Company
15th Jul 20217:00 amRNSH1 2021 Update
18th Jun 20214:36 pmRNSPrice Monitoring Extension
18th Jun 20213:20 pmRNSResult of AGM
27th May 20214:40 pmRNSSecond Price Monitoring Extn
27th May 20214:36 pmRNSPrice Monitoring Extension
27th May 20212:06 pmRNSSecond Price Monitoring Extn
27th May 20212:00 pmRNSPrice Monitoring Extension
27th May 202111:06 amRNSSecond Price Monitoring Extn
27th May 202111:00 amRNSPrice Monitoring Extension
27th May 20217:00 amRNSHolding(s) in Company
25th May 20217:00 amRNSAnnual Financial Report
21st May 20215:50 pmRNSNotice of Results
15th Apr 20217:00 amRNSQ1 2021 Update
1st Mar 20215:36 pmRNSDirector/PDMR Shareholding
24th Feb 20217:00 amRNSDirector/PDMR Shareholding
19th Feb 20217:00 amRNSDirector/PDMR Shareholding
19th Jan 20217:00 amRNSMarket Update
22nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20204:35 pmRNSPrice Monitoring Extension
22nd Dec 20202:05 pmRNSSecond Price Monitoring Extn
22nd Dec 20202:00 pmRNSPrice Monitoring Extension
16th Dec 202011:50 amRNSGrant of Share Options
16th Oct 20207:00 amRNSQ3 2020 Update
13th Oct 20204:40 pmRNSSecond Price Monitoring Extn
13th Oct 20204:35 pmRNSPrice Monitoring Extension
29th Sep 20207:00 amRNSINTERIM RESULTS
23rd Sep 20207:09 amRNSPrice Monitoring Extension
23rd Sep 20207:07 amRNSSecond Price Monitoring Extn
23rd Sep 20207:04 amRNSPrice Monitoring Extension
23rd Sep 20207:01 amRNSSecond Price Monitoring Extn
22nd Sep 20204:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20204:36 pmRNSPrice Monitoring Extension
22nd Sep 20202:05 pmRNSSecond Price Monitoring Extn
22nd Sep 20202:00 pmRNSPrice Monitoring Extension
22nd Sep 20207:00 amRNSDebt Refinancing Signed
26th Aug 20207:00 amRNSDebt Update
31st Jul 20208:00 amRNSLaunch of new website
22nd Jul 202011:06 amRNSSecond Price Monitoring Extn
22nd Jul 202011:00 amRNSPrice Monitoring Extension
22nd Jul 20207:00 amRNSCorporate Update
30th Jun 20202:36 pmRNSDebt Update
30th Jun 202011:52 amRNSResult of AGM
26th Jun 20201:26 pmRNSChange of venue for AGM on 30 June 2020
26th Jun 20207:00 amRNSIO#8 and Debt Update
27th May 20207:00 amRNSFinal Results
19th May 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.